Fibrinolytic therapy for portal vein thrombosis

The Lancet

Volumn 337, Issue 8754, 1991, Pages 1416-

  Bizollon, Thierry ^a   Bissuel, François ^a   Detry, Laurent ^a   Trepo, Christian ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; CASE REPORT; FEMALE; FIBRINOLYSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; CASE REPORT; FEMALE; HUMAN; INJECTIONS, INTRALESIONAL; PORTAL VEIN; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0025872846     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(91)93101-E     Document Type: Letter

References (5)

1. Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states
2. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator
3. Percutaneous transhepatic recanalization and thrombolysis of the supenor mesentenc vein
4. Thrombolytic therapy for supenor vena cava syndrome
5. Spontaneous subclavian vein thrombosis: a successful combined approach of local thrombolytic therapy followed by first-rib resection